Dr Emma Haapaniemi joined NCMM as a group leader in January 2019. Her research programme will focus on rare immune diseases caused by genetics and rare acquired autoimmune diseases.
Professor Janna Saarela joined NCMM as Director in January 2019. She was previously head of the Technology Centre and Deputy Director of the Institute for Molecular Medicine Finland (FIMM), which is also part of the Nordic EMBL Partnership. Here she shares some insight into her research, and what she hopes the future holds for NCMM.
- 2018 NCMM Annual Report published May 16, 2019 11:15 AM
- NCMM awards 4mNOK in Collaborative Grants May 3, 2019 1:54 PM
- NCMM's Chemical Biology Platform involved in pilot project to improve research reproducibility Apr. 26, 2019 2:19 PM